- Home
- ABVX vs EVER Comparison
ABVX vs EVER Comparison
Compare ABVX & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- EVER
- Stock Information
- Founded
- ABVX 2013
- EVER 2008
- Country
- ABVX France
- EVER United States
- Employees
- ABVX N/A
- EVER N/A
- Industry
- ABVX
- EVER Computer Software: Programming Data Processing
- Sector
- ABVX
- EVER Technology
- Exchange
- ABVX Nasdaq
- EVER Nasdaq
- Market Cap
- ABVX 722.3M
- EVER 664.3M
- IPO Year
- ABVX N/A
- EVER 2018
- Fundamental
- Price
- ABVX $6.16
- EVER $18.47
- Analyst Decision
- ABVX Strong Buy
- EVER Strong Buy
- Analyst Count
- ABVX 7
- EVER 6
- Target Price
- ABVX $37.86
- EVER $31.67
- AVG Volume (30 Days)
- ABVX 216.6K
- EVER 442.0K
- Earning Date
- ABVX 09-09-2024
- EVER 02-24-2025
- Dividend Yield
- ABVX N/A
- EVER N/A
- EPS Growth
- ABVX N/A
- EVER N/A
- EPS
- ABVX N/A
- EVER 0.38
- Revenue
- ABVX $9,676,417.00
- EVER $408,440,000.00
- Revenue This Year
- ABVX $31.67
- EVER $72.34
- Revenue Next Year
- ABVX $759.77
- EVER $18.98
- P/E Ratio
- ABVX N/A
- EVER $49.06
- Revenue Growth
- ABVX 100.87
- EVER 27.43
- 52 Week Low
- ABVX $5.54
- EVER $10.65
- 52 Week High
- ABVX $17.02
- EVER $28.09
- Technical
- Relative Strength Index (RSI)
- ABVX 30.30
- EVER 47.50
- Support Level
- ABVX $5.54
- EVER $17.20
- Resistance Level
- ABVX $6.46
- EVER $19.09
- Average True Range (ATR)
- ABVX 0.51
- EVER 0.84
- MACD
- ABVX -0.04
- EVER -0.08
- Stochastic Oscillator
- ABVX 30.10
- EVER 33.38
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.